Breakthrough Triple-Action Cancer Jab Eradicates Tumors in International Trials
A groundbreaking triple-action cancer jab, amivantamab, has shown the ability to completely eradicate tumors in trial patients resistant to standard therapies.
News & Insights Across Asia
A groundbreaking triple-action cancer jab, amivantamab, has shown the ability to completely eradicate tumors in trial patients resistant to standard therapies.
South African researchers develop handheld TB detector using blood samples, delivering results in 30 minutes to revolutionize disease management in high-risk areas.
China’s NSFC releases 2026 guidelines for global sustainability partnerships, focusing on climate, health, and green resources with international collaborators.
Landmark Swedish trial shows AI improves breast cancer detection by 9%, reduces interval cancers by 12%, signaling potential for global healthcare systems.
Chinese scientists develop a predictive model for human organ aging, enabling targeted disease prevention and personalized anti-aging interventions.
An international event highlights how innovative health solutions and technology are guiding new lifestyles in the post-pandemic era, focusing on modern medicine, aging solutions, and global health cooperation.